Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: KYE PHARMACEUTICALS INC.
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02550679 | KYE PHARMACEUTICALS INC. | ACCRUFER | Human | Yes | PRESCRIPTION | 1 | IRON (FERRIC MALTOL) | 30 MG |
| Approved | 02561506 | KYE PHARMACEUTICALS INC. | AGAMREE | Human | Yes | PRESCRIPTION | 1 | VAMOROLONE | 40 MG / ML |
| Marketed | 02510219 | KYE PHARMACEUTICALS INC. | CORZYNA | Human | Yes | PRESCRIPTION | 1 | RANOLAZINE | 500 MG |
| Marketed | 02510227 | KYE PHARMACEUTICALS INC. | CORZYNA | Human | Yes | PRESCRIPTION | 1 | RANOLAZINE | 1000 MG |
| Approved | 02558947 | KYE PHARMACEUTICALS INC. | CORZYNA | Human | Yes | PRESCRIPTION | 1 | RANOLAZINE | 375 MG |
| Approved | 02558955 | KYE PHARMACEUTICALS INC. | CORZYNA | Human | Yes | PRESCRIPTION | 1 | RANOLAZINE | 750 MG |
| Approved | 02559781 | KYE PHARMACEUTICALS INC. | DYANAVEL XR | Human | Yes | CONTROLLED DRUGS (CDSA I) | 1 | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) | 2.5 MG / ML |
| Approved | 02559803 | KYE PHARMACEUTICALS INC. | DYANAVEL XR | Human | Yes | CONTROLLED DRUGS (CDSA I) | 1 | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) | 5 MG |
| Approved | 02559811 | KYE PHARMACEUTICALS INC. | DYANAVEL XR | Human | Yes | CONTROLLED DRUGS (CDSA I) | 1 | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) | 10 MG |
| Approved | 02559838 | KYE PHARMACEUTICALS INC. | DYANAVEL XR | Human | Yes | CONTROLLED DRUGS (CDSA I) | 1 | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) | 15 MG |
| Approved | 02559846 | KYE PHARMACEUTICALS INC. | DYANAVEL XR | Human | Yes | CONTROLLED DRUGS (CDSA I) | 1 | AMPHETAMINE (AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE (COMPLEXED WITH SODIUM POLYSTYRENE SULFONATE)) | 20 MG |
| Marketed | 02502984 | KYE PHARMACEUTICALS INC. | FIRDAPSE | Human | Yes | PRESCRIPTION | 1 | AMIFAMPRIDINE (AMIFAMPRIDINE PHOSPHATE) | 10 MG |
| Marketed | 02512653 | KYE PHARMACEUTICALS INC. | KYE-ESCITALOPRAM | Human | Yes | PRESCRIPTION | 1 | ESCITALOPRAM (ESCITALOPRAM OXALATE) | 15 MG |
| Marketed | 02541602 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER CHEWABLE TABLETS | Human | Yes | CONTROLLED DRUGS (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
| Marketed | 02541610 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER CHEWABLE TABLETS | Human | Yes | CONTROLLED DRUGS (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 30 MG |
| Marketed | 02541629 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER CHEWABLE TABLETS | Human | Yes | CONTROLLED DRUGS (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 40 MG |
| Marketed | 02541637 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER ORAL SUSPENSION | Human | Yes | CONTROLLED DRUGS (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG / ML |
Application information
Related information
Contact us
Version 4.0.3